Francois F. Aubin

CHU De Clermont Ferrand

Clermont-ferrand, FR

Expertise in

conditions

CHU De Clermont Ferrand

Clermont-ferrand, FR

OverviewLocationsClinical Research

Overview

Francois Aubin practices in Clermont-ferrand, France. Mr. Aubin is highly rated in 23 conditions, according to our data. His top areas of expertise are Dissecting Cellulitis of the Scalp, Merkel Cell Carcinoma, Melanoma, Warts, and Tubal Ligation.

His clinical research consists of co-authoring 345 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

CHU de Clermont Ferrand
Clermont-ferrand, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Combination of Targeted Therapy (Encorafenib and Binimetinib) Followed by Combination of Immunotherapy (Ipilimumab and Nivolumab) vs Immediate Combination of Immunotherapy in Patients With Unresectable or Metastatic Melanoma With BRAF V600 Mutation : an EORTC Randomized Phase II Study (EBIN)

Enrollment Status: Active_not_recruiting

Publish Date: August 01, 2025

Intervention Type: Drug

Study Drugs: Nivolumab + Ipilimumab, Encorafenib + Binimetinib

Study Phase: Phase 2

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine

Enrollment Status: Completed

Publish Date: May 14, 2024

Intervention Type: Drug

Study Drugs: Baricitinib, Corticosteroid

Study Phase: Phase 3

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

Enrollment Status: Completed

Publish Date: December 06, 2022

Intervention Type: Drug

Study Drugs: Imiquimod Cream+Surgery, Surgery

Study Phase: Phase 3

A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)

Enrollment Status: Terminated

Publish Date: November 08, 2022

Intervention Type: Drug

Study Drugs: Ipilimumab, IMO-2125

Study Phase: Phase 3

Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis and Assessment of Their Relations With the Risk of Cardiovascular Disease

Enrollment Status: Completed

Publish Date: February 12, 2018

Intervention Type: Other

Study Phase: Not Applicable

View 4 Less Clinical Trials

344 Total Publications

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Journal: Physical review letters

Published: August 13, 2025

View All 344 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Aubin's expertise for a condition

ConditionClose